JPRN-UMIN000007386已完成2 期
A Multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanved non-squamous non-small cell lung cancer - Phase II study of S-1 plus bevacizumab
Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine0 个研究点目标入组 28 人开始时间: 2012年2月27日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Squamous cell carcinoma (2)Previously untreated with platinum-based chemotherapy as a first line treatment (3)Discontinued bevacizumab due to its toxicity during a first line treatment (4)Severe complications (5)Symptomatic brain metastasis (6)Tumor cavitation (7)History or complication of hemoptysis with 2.5mL per time or more (8)Continuouis bloody phlegm more than 1 week. History or complication of bloody phlegm treated with continuous oral hemostatic agent. History or complication of bloody phlegm treated with infusional hemostatic agent. (9)Uncontrollable hypertension (10)History of GI perforation (11)Planning of surgery (12)Active concomitant malignancy (13)Severe drug allergy (14)Pregnancy or lactation (15)Severe psychological illness (16)History of thoracic radiotherapy (17)Systemic steroid treatment
研究者
相似试验
已完成
2 期
Multicenter phase II study of second-line S-1 monotherapy in patients with gemcitabine-refractory advanced biliary tract cancerGemcitabine-refractory advanced biliary tract cancerJPRN-UMIN000001614Faculty of Medicine, University of Tokyo22
进行中（未招募）
不适用
Study of a new drug combination to treat Chronic Lymphocytic Leukemiantreated or Relapsed Chronic Lymphocytic LeukaemiaMedDRA version: 14.1Level: LLTClassification code 10008968Term: Chronic lymphocytic leukaemia stage A(0)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005178-43-ITGLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.80
进行中（未招募）
1 期
Study of a new drug combination to treat Chronic Lymphocytic LeukemiaEUCTR2011-005178-43-GRGlaxoSmithKline Research & Development Limited80
进行中（未招募）
1 期
Study of a new drug combination to treat Chronic Lymphocytic Leukemia.EUCTR2011-005178-43-ESGlaxoSmithKline, S.A.97
进行中（未招募）
不适用
Study of a new drug combination to treat Chronic Lymphocytic Leukemiantreated or Relapsed Chronic Lymphocytic LeukaemiaMedDRA version: 14.1Level: LLTClassification code 10008968Term: Chronic lymphocytic leukaemia stage A(0)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005178-43-DEGlaxoSmithKline Research & Development Limited80